Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group.

Weinberg OK, Hasserjian RP, Baraban E, Ok CY, Geyer JT, Philip JKSS, Kurzer JH, Rogers HJ, Nardi V, Stone RM, Garcia JS, Hsi ED, Bagg A, Wang SA, Orazi A, Arber DA.

Mod Pathol. 2019 Apr 18. doi: 10.1038/s41379-019-0263-3. [Epub ahead of print]

PMID:
31000771
2.

Case 35-2018: A Woman with Back Pain and a Remote History of Breast Cancer. Reply.

Nardi V.

N Engl J Med. 2019 Apr 11;380(15):e22. doi: 10.1056/NEJMc1817336. No abstract available.

PMID:
30970202
3.

Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.

Thierauf J, Ramamurthy N, Jo VY, Robinson H, Frazier RP, Gonzalez J, Pacula M, Dominguez Meneses E, Nose V, Nardi V, Dias-Santagata D, Le LP, Lin DT, Faquin WC, Wirth LJ, Hess J, Iafrate AJ, Lennerz JK.

Oncologist. 2019 Mar 29. pii: theoncologist.2018-0515. doi: 10.1634/theoncologist.2018-0515. [Epub ahead of print]

PMID:
30926674
4.

Clinicopathological and molecular features of SF3B1-mutated myeloproliferative neoplasms.

Boiocchi L, Hasserjian RP, Pozdnyakova O, Wong WJ, Lennerz JK, Le LP, Dias-Santagata D, Iafrate AJ, Hobbs GS, Nardi V.

Hum Pathol. 2019 Apr;86:1-11. doi: 10.1016/j.humpath.2018.11.022. Epub 2018 Dec 27.

PMID:
30594750
5.

Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.

Bale TA, Jordan JT, Rapalino O, Ramamurthy N, Jessop N, DeWitt JC, Nardi V, Alvarez MM, Frosch M, Batchelor TT, Louis DN, Iafrate AJ, Cahill DP, Lennerz JK.

Neuro Oncol. 2019 May 6;21(5):596-605. doi: 10.1093/neuonc/noy201.

PMID:
30496526
6.

Feasibility of Perioperative Micro-Computed Tomography of Human Lung Cancer Specimens: A Pilot Study.

Troschel FM, Gottumukkala RV, DiCorpo D, Mario J, Ott HC, Wright CD, Muniappan A, Lanuti M, Yang K, Shepard JO, Nardi V, Michaelson JS, Hariri LP, Fintelmann FJ.

Arch Pathol Lab Med. 2019 Mar;143(3):319-325. doi: 10.5858/arpa.2018-0249-OA. Epub 2018 Nov 20.

PMID:
30457896
7.

Case 35-2018: A 68-Year-Old Woman with Back Pain and a Remote History of Breast Cancer.

Bardia A, Hovnanian MD, Brachtel EF, Nardi V.

N Engl J Med. 2018 Nov 15;379(20):1946-1953. doi: 10.1056/NEJMcpc1616400. No abstract available.

PMID:
30428289
8.

Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation.

Chougule A, Taylor MS, Nardi V, Chebib I, Cote GM, Choy E, Nielsen GP, Deshpande V.

Am J Surg Pathol. 2019 Feb;43(2):220-228. doi: 10.1097/PAS.0000000000001183.

PMID:
30379650
9.

Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer.

Dagogo-Jack I, Azzolli CG, Fintelmann F, Mino-Kenudson M, Farago AF, Gainor JF, Jiang G, Piotrowska Z, Heist RS, Lennes IT, Temel JS, Mooradian MJ, Lin JJ, Digumarthy SR, Batten JM, Robinson H, Nose V, Rivera M, Nardi V, Dias-Santagata D, Le LP, Sequist LV, Pitman M, Shepard JO, Shaw AT, Iafrate AJ, Lennerz JK.

JCO Precis Oncol. 2018;2018. doi: 10.1200/PO.17.00299. Epub 2018 Jul 24.

10.

Artificial Intelligence Approach for Variant Reporting.

Zomnir MG, Lipkin L, Pacula M, Meneses ED, MacLeay A, Duraisamy S, Nadhamuni N, Al Turki SH, Zheng Z, Rivera M, Nardi V, Dias-Santagata D, Iafrate AJ, Le LP, Lennerz JK.

JCO Clin Cancer Inform. 2018;2. doi: 10.1200/CCI.16.00079. Epub 2018 Mar 22.

11.

A Nanopore Sequencing-Based Assay for Rapid Detection of Gene Fusions.

Jeck WR, Lee J, Robinson H, Le LP, Iafrate AJ, Nardi V.

J Mol Diagn. 2019 Jan;21(1):58-69. doi: 10.1016/j.jmoldx.2018.08.003. Epub 2018 Sep 28.

PMID:
30273778
12.

Incidence of Mismatch Repair Protein Deficiency and Associated Clinicopathologic Features in a Cohort of 104 Ovarian Endometrioid Carcinomas.

Bennett JA, Pesci A, Morales-Oyarvide V, Da Silva A, Nardi V, Oliva E.

Am J Surg Pathol. 2019 Feb;43(2):235-243. doi: 10.1097/PAS.0000000000001165.

PMID:
30256257
13.

Severe neurologic and hepatic toxicity in a newborn prenatally exposed to methamphetamine. A case report.

Maranella E, Mareri A, Nardi V, Di Natale C, Di Luca L, Conte E, Pannone V, Catalucci A, Di Fabio S.

Brain Dev. 2019 Feb;41(2):191-194. doi: 10.1016/j.braindev.2018.08.010. Epub 2018 Sep 10.

PMID:
30213441
14.

"Z4" Complex Member Fusions in NUT Carcinoma: Implications for a Novel Oncogenic Mechanism.

Shiota H, Elya JE, Alekseyenko AA, Chou PM, Gorman SA, Barbash O, Becht K, Danga K, Kuroda MI, Nardi V, French CA.

Mol Cancer Res. 2018 Dec;16(12):1826-1833. doi: 10.1158/1541-7786.MCR-18-0474. Epub 2018 Aug 23.

PMID:
30139738
15.

Uric acid is an independent predictor of cardiac allograft vasculopathy after heart transplantation.

Asleh R, Prasad M, Briasoulis A, Nardi V, Adigun R, Edwards BS, Pereira NL, Daly RC, Lerman A, Kushwaha SS.

J Heart Lung Transplant. 2018 Sep;37(9):1083-1092. doi: 10.1016/j.healun.2018.04.017. Epub 2018 May 1.

PMID:
29802086
16.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.

Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia NV, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A Jr, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R.

Nat Commun. 2018 May 22;9(1):2024. doi: 10.1038/s41467-018-04356-9.

17.

High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.

Patel SS, Kuo FC, Gibson CJ, Steensma DP, Soiffer RJ, Alyea EP 3rd, Chen YA, Fathi AT, Graubert TA, Brunner AM, Wadleigh M, Stone RM, DeAngelo DJ, Nardi V, Hasserjian RP, Weinberg OK.

Blood. 2018 Jun 21;131(25):2816-2825. doi: 10.1182/blood-2018-01-828467. Epub 2018 May 3.

PMID:
29724895
18.

Laboratory testing in BCR-ABL1-like (Philadelphia-like) B-lymphoblastic leukemia/lymphoma.

Siegele BJ, Nardi V.

Am J Hematol. 2018 Jul;93(7):971-977. doi: 10.1002/ajh.25126. Epub 2018 May 15.

PMID:
29696694
19.

Peptidomimetic nitrile inhibitors of malarial protease falcipain-2 with high selectivity against human cathepsins.

Nizi E, Sferrazza A, Fabbrini D, Nardi V, Andreini M, Graziani R, Gennari N, Bresciani A, Paonessa G, Harper S.

Bioorg Med Chem Lett. 2018 May 15;28(9):1540-1544. doi: 10.1016/j.bmcl.2018.03.069. Epub 2018 Mar 26.

PMID:
29615344
20.

MET Amplification in Esophageal Squamous Carcinoma.

Michaels PD, Robinson H, Nardi V, Iafrate AJ, Le L, Lennerz JK.

Int J Surg Pathol. 2018 Dec;26(8):731-732. doi: 10.1177/1066896918764301. Epub 2018 Mar 19. No abstract available.

PMID:
29552946
21.

Syphilis of the Aerodigestive Tract.

Tse JY, Chan MP, Ferry JA, Deshpande V, Sohani AR, Nardi V, Schaffer A, Nazarian RM, Zukerberg LR.

Am J Surg Pathol. 2018 Apr;42(4):472-478. doi: 10.1097/PAS.0000000000000987.

PMID:
29135519
22.

Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.

Church AJ, Calicchio ML, Nardi V, Skalova A, Pinto A, Dillon DA, Gomez-Fernandez CR, Manoj N, Haimes JD, Stahl JA, Dela Cruz FS, Tannenbaum-Dvir S, Glade-Bender JL, Kung AL, DuBois SG, Kozakewich HP, Janeway KA, Perez-Atayde AR, Harris MH.

Mod Pathol. 2018 Mar;31(3):463-473. doi: 10.1038/modpathol.2017.127. Epub 2017 Nov 3.

23.

A B Cell Regulome Links Notch to Downstream Oncogenic Pathways in Small B Cell Lymphomas.

Ryan RJH, Petrovic J, Rausch DM, Zhou Y, Lareau CA, Kluk MJ, Christie AL, Lee WY, Tarjan DR, Guo B, Donohue LKH, Gillespie SM, Nardi V, Hochberg EP, Blacklow SC, Weinstock DM, Faryabi RB, Bernstein BE, Aster JC, Pear WS.

Cell Rep. 2017 Oct 17;21(3):784-797. doi: 10.1016/j.celrep.2017.09.066.

24.

Electromagnetic fields in neonatal incubators: the reasons for an alert.

Bellieni CV, Nardi V, Buonocore G, Di Fabio S, Pinto I, Verrotti A.

J Matern Fetal Neonatal Med. 2019 Feb;32(4):695-699. doi: 10.1080/14767058.2017.1390559. Epub 2017 Oct 23.

PMID:
28988507
25.

Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma.

Hung YP, Dong F, Watkins JC, Nardi V, Bueno R, Dal Cin P, Godleski JJ, Crum CP, Chirieac LR.

JAMA Oncol. 2018 Feb 1;4(2):235-238. doi: 10.1001/jamaoncol.2017.2918.

26.

GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.

Ritterhouse LL, Vivero M, Mino-Kenudson M, Sholl LM, Iafrate AJ, Nardi V, Dong F.

Mod Pathol. 2017 Dec;30(12):1720-1727. doi: 10.1038/modpathol.2017.88. Epub 2017 Aug 4.

27.

Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.

Bennett JA, Nardi V, Rouzbahman M, Morales-Oyarvide V, Nielsen GP, Oliva E.

Mod Pathol. 2017 Oct;30(10):1489-1503. doi: 10.1038/modpathol.2017.69. Epub 2017 Jun 30.

28.

Pain perception in NICU: a pilot questionnaire.

Bellieni CV, Tei M, Cornacchione S, Di Lucia S, Nardi V, Verrotti A, Buonocore G.

J Matern Fetal Neonatal Med. 2018 Jul;31(14):1921-1923. doi: 10.1080/14767058.2017.1332038. Epub 2017 Jun 2.

PMID:
28514889
29.

Case 5-2017. A 19-Year-Old Man with Hematuria and a Retroperitoneal Mass.

Blute ML Sr, Abramson JS, Cronin KC, Nardi V.

N Engl J Med. 2017 Feb 16;376(7):684-692. doi: 10.1056/NEJMcpc1610100. No abstract available.

PMID:
28199810
30.

Fibrin-associated EBV-positive Large B-Cell Lymphoma: An Indolent Neoplasm With Features Distinct From Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation.

Boyer DF, McKelvie PA, de Leval L, Edlefsen KL, Ko YH, Aberman ZA, Kovach AE, Masih A, Nishino HT, Weiss LM, Meeker AK, Nardi V, Palisoc M, Shao L, Pittaluga S, Ferry JA, Harris NL, Sohani AR.

Am J Surg Pathol. 2017 Mar;41(3):299-312. doi: 10.1097/PAS.0000000000000775.

PMID:
28195879
31.

A phase 2 and biomarker study of cabozantinib in patients with advanced cholangiocarcinoma.

Goyal L, Zheng H, Yurgelun MB, Abrams TA, Allen JN, Cleary JM, Knowles M, Regan E, Reardon A, Khachatryan A, Jain RK, Nardi V, Borger DR, Duda DG, Zhu AX.

Cancer. 2017 Jun 1;123(11):1979-1988. doi: 10.1002/cncr.30571. Epub 2017 Feb 13.

32.

Uptake of cervical cancer screening among the migrant population of Prato Province, Italy.

Comparetto C, Epifani C, Manca MC, Lachheb A, Bravi S, Cipriani F, Bellomo F, Olivieri S, Fiaschi C, Di Marco L, Nardi V, Spinelli G, Borruto F.

Int J Gynaecol Obstet. 2017 Mar;136(3):309-314. doi: 10.1002/ijgo.12067. Epub 2016 Dec 19.

PMID:
28099681
33.

Diagnostic work-up of acute myeloid leukemia.

Weinberg OK, Sohani AR, Bhargava P, Nardi V.

Am J Hematol. 2017 Mar;92(3):317-321. doi: 10.1002/ajh.24648. Epub 2017 Feb 3. Review.

34.

Metastatic Breast Cancer With ESR1 Mutation: Clinical Management Considerations From the Molecular and Precision Medicine (MAP) Tumor Board at Massachusetts General Hospital.

Bardia A, Iafrate JA, Sundaresan T, Younger J, Nardi V.

Oncologist. 2016 Sep;21(9):1035-40. doi: 10.1634/theoncologist.2016-0240. Epub 2016 Aug 22.

35.

EBV-negative monomorphic B-cell post-transplant lymphoproliferative disorders are pathologically distinct from EBV-positive cases and frequently contain TP53 mutations.

Courville EL, Yohe S, Chou D, Nardi V, Lazaryan A, Thakral B, Nelson AC, Ferry JA, Sohani AR.

Mod Pathol. 2016 Oct;29(10):1200-11. doi: 10.1038/modpathol.2016.130. Epub 2016 Jul 22.

36.

Primary Endometrial Marginal Zone Lymphoma (MALT Lymphoma): A Unique Clinicopathologic Entity.

Bennett JA, Oliva E, Nardi V, Lindeman N, Ferry JA, Louissaint A Jr.

Am J Surg Pathol. 2016 Sep;40(9):1217-23. doi: 10.1097/PAS.0000000000000683.

PMID:
27340748
37.

Ilex paraguariensis Promotes Orofacial Pain Relief After Formalin Injection: Involvement of Noradrenergic Pathway.

de Carvalho EF, de Oliveira SK, Nardi VK, Gelinski TC, Bortoluzzi MC, Maraschin M, Nardi GM.

Pharmacognosy Res. 2016 Mar;8(Suppl 1):S31-7. doi: 10.4103/0974-8490.178643.

38.

Genetic Testing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Nardi V, Hasserjian RP.

Surg Pathol Clin. 2016 Mar;9(1):143-63. doi: 10.1016/j.path.2015.10.004. Review.

PMID:
26940274
39.

Temporal stability of parasite distribution and genetic variability values of Contracaecum osculatum sp. D and C. osculatum sp. E (Nematoda: Anisakidae) from fish of the Ross Sea (Antarctica).

Mattiucci S, Cipriani P, Paoletti M, Nardi V, Santoro M, Bellisario B, Nascetti G.

Int J Parasitol Parasites Wildl. 2015 Oct 22;4(3):356-67. doi: 10.1016/j.ijppaw.2015.10.004. eCollection 2015 Dec.

40.

Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Platt MY, Fathi AT, Borger DR, Brunner AM, Hasserjian RP, Balaj L, Lum A, Yip S, Dias-Santagata D, Zheng Z, Le LP, Graubert TA, Iafrate AJ, Nardi V.

J Mol Diagn. 2015 Nov;17(6):661-8. doi: 10.1016/j.jmoldx.2015.06.004. Epub 2015 Aug 30.

41.

Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma.

Goyal L, Govindan A, Sheth RA, Nardi V, Blaszkowsky LS, Faris JE, Clark JW, Ryan DP, Kwak EL, Allen JN, Murphy JE, Saha SK, Hong TS, Wo JY, Ferrone CR, Tanabe KK, Chong DQ, Deshpande V, Borger DR, Iafrate AJ, Bardeesy N, Zheng H, Zhu AX.

Oncologist. 2015 Sep;20(9):1019-27. doi: 10.1634/theoncologist.2015-0210. Epub 2015 Aug 5.

42.

Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.

Ryan RJ, Drier Y, Whitton H, Cotton MJ, Kaur J, Issner R, Gillespie S, Epstein CB, Nardi V, Sohani AR, Hochberg EP, Bernstein BE.

Cancer Discov. 2015 Oct;5(10):1058-71. doi: 10.1158/2159-8290.CD-15-0370. Epub 2015 Jul 30.

43.

Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma.

O'Donnell E, Mahindra A, Yee AJ, Nardi V, Birrer N, Horick N, Borger D, Finkelstein D, Iafrate JA, Raje N.

EBioMedicine. 2014 Nov 18;2(1):71-3. doi: 10.1016/j.ebiom.2014.11.008. eCollection 2015 Jan.

44.

Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information.

Nardi V, Pulluqi O, Abramson JS, Dal Cin P, Hasserjian RP.

Am J Hematol. 2015 Jun;90(6):529-33. doi: 10.1002/ajh.24008. Epub 2015 May 3.

45.

Case records of the Massachusetts General Hospital. Case 40-2014. A 57-year-old man with inguinal pain, lymphadenopathy, and HIV infection.

Gandhi RT, Alkasab TK, Nardi V, Branda JA.

N Engl J Med. 2014 Dec 25;371(26):2511-20. doi: 10.1056/NEJMcpc1404518. No abstract available.

PMID:
25539108
46.

High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome.

Cleven AH, Nardi V, Ok CY, Goswami M, Dal Cin P, Zheng Z, Iafrate AJ, Abdul Hamid MA, Wang SA, Hasserjian RP.

Mod Pathol. 2015 Apr;28(4):552-63. doi: 10.1038/modpathol.2014.153. Epub 2014 Nov 21.

47.

Case records of the Massachusetts General Hospital. Case 28-2014. A 39-year-old man with a rash, headache, fever, nausea, and photophobia.

Pukkila-Worley R, Nardi V, Branda JA.

N Engl J Med. 2014 Sep 11;371(11):1051-60. doi: 10.1056/NEJMcpc1405886. No abstract available.

PMID:
25207769
48.

A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.

Grabiner BC, Nardi V, Birsoy K, Possemato R, Shen K, Sinha S, Jordan A, Beck AH, Sabatini DM.

Cancer Discov. 2014 May;4(5):554-63. doi: 10.1158/2159-8290.CD-13-0929. Epub 2014 Mar 14.

49.

Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in HeLa cells.

Cocco E, Porrini V, Derosas M, Nardi V, Biasiotto G, Maccarinelli F, Zanella I.

Mol Biol Rep. 2013 Dec;40(12):6757-64. doi: 10.1007/s11033-013-2792-z. Epub 2013 Sep 25.

PMID:
24065548
50.

Case records of the Massachusetts General Hospital. Case 24-2013. A 53-year-old woman with erythroderma, pruritus, and lymphadenopathy.

Carter JB, Barnes JA, Niell BL, Nardi V.

N Engl J Med. 2013 Aug 8;369(6):559-69. doi: 10.1056/NEJMcpc1201415. No abstract available.

PMID:
23924007

Supplemental Content

Support Center